Twenty-First Century Fox, Inc. (FOXA) Forms $37.02 Double Top; Park West Asset Management Boosted Eagle Pharmaceuticals (EGRX) Stake

Park West Asset Management Llc increased Eagle Pharmaceuticals Inc (EGRX) stake by 123.33% reported in 2017Q3 SEC filing. Park West Asset Management Llc acquired 501,557 shares as Eagle Pharmaceuticals Inc (EGRX)’s stock rose 7.49%. The Park West Asset Management Llc holds 908,220 shares with $54.17 million value, up from 406,663 last quarter. Eagle Pharmaceuticals Inc now has $847.88 million valuation. The stock increased 2.06% or $1.15 during the last trading session, reaching $57.05. About 221,495 shares traded. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has risen 79.40% since March 8, 2017 and is uptrending. It has outperformed by 62.70% the S&P500.

Twenty-First Century Fox, Inc. (FOXA) formed double top with $39.98 target or 8.00% above today’s $37.02 share price. Twenty-First Century Fox, Inc. (FOXA) has $68.17B valuation. The stock decreased 1.39% or $0.52 during the last trading session, reaching $37.02. About 7.47M shares traded. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) has declined 2.90% since March 8, 2017 and is downtrending. It has underperformed by 19.60% the S&P500.

Analysts await Twenty-First Century Fox, Inc. (NASDAQ:FOXA) to report earnings on May, 9. They expect $0.56 EPS, up 3.70% or $0.02 from last year’s $0.54 per share. FOXA’s profit will be $1.03 billion for 16.53 P/E if the $0.56 EPS becomes a reality. After $0.42 actual EPS reported by Twenty-First Century Fox, Inc. for the previous quarter, Wall Street now forecasts 33.33% EPS growth.

Among 33 analysts covering Twenty-First Century Fox Inc (NASDAQ:FOXA), 21 have Buy rating, 1 Sell and 11 Hold. Therefore 64% are positive. Twenty-First Century Fox Inc had 100 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Sunday, September 10 by KeyBanc Capital Markets. As per Wednesday, June 14, the company rating was maintained by Jefferies. The rating was maintained by Jefferies on Monday, July 17 with “Buy”. The firm has “Buy” rating by BMO Capital Markets given on Wednesday, August 9. On Friday, August 7 the stock rating was downgraded by TheStreet to “Strong-Buy”. The company was upgraded on Wednesday, December 14 by Brean Capital. FBR Capital maintained Twenty-First Century Fox, Inc. (NASDAQ:FOXA) rating on Tuesday, February 9. FBR Capital has “Mkt Perform” rating and $27 target. Needham downgraded the stock to “Buy” rating in Monday, August 24 report. Cowen & Co maintained it with “Hold” rating and $37.0 target in Friday, December 22 report. KeyBanc Capital Markets maintained the shares of FOXA in report on Sunday, November 19 with “Buy” rating.

Among 4 analysts covering Eagle Pharma (NASDAQ:EGRX), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Eagle Pharma had 23 analyst reports since July 29, 2015 according to SRatingsIntel. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, July 25 report. The stock has “Sell” rating by Mizuho on Monday, February 26. On Wednesday, August 9 the stock rating was maintained by Piper Jaffray with “Buy”. The firm earned “Buy” rating on Sunday, November 5 by RBC Capital Markets. As per Wednesday, August 9, the company rating was maintained by Mizuho. On Monday, October 2 the stock rating was maintained by RBC Capital Markets with “Buy”. RBC Capital Markets maintained Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) on Friday, September 1 with “Buy” rating. The stock of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has “Sell” rating given on Thursday, October 26 by Mizuho. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, November 3. As per Monday, February 26, the company rating was maintained by RBC Capital Markets.

Park West Asset Management Llc decreased Teekay Offshore Partners LP (NYSE:TOO) stake by 250,000 shares to 2.43 million valued at $5.78 million in 2017Q3. It also reduced Lithia Mtrs Inc (NYSE:LAD) stake by 282,019 shares and now owns 770,131 shares. Smart Global Hldgs Inc was reduced too.